BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15723240)

  • 1. Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment.
    Trog D; Moenkemann H; Haertel N; Schüller H; Golubnitschaja O
    Amino Acids; 2005 Mar; 28(2):213-9. PubMed ID: 15723240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells.
    Trog D; Yeghiazaryan K; Fountoulakis M; Friedlein A; Moenkemann H; Haertel N; Schueller H; Breipohl W; Schild H; Leppert D; Golubnitschaja O
    Eur J Pharmacol; 2006 Aug; 542(1-3):8-15. PubMed ID: 16806166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a side population of astrocytoma cells in response to temozolomide.
    Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
    J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions.
    Trog D; Moenkemann H; Breipohl W; Schueller H; Schild H; Golubnitschaja O
    Amino Acids; 2007; 32(3):373-9. PubMed ID: 17077962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions.
    Trog D; Fountoulakis M; Friedlein A; Golubnitschaja O
    Proteomics; 2006 May; 6(9):2924-30. PubMed ID: 16596702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
    Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y
    J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of vimentin expression in low-density malignant glioma cells as immediate and late effects under irradiation and temozolomide treatment.
    Trog D; Yeghiazaryan K; Schild HH; Golubnitschaja O
    Amino Acids; 2008 May; 34(4):539-45. PubMed ID: 18046501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
    Tabatabai G; Frank B; Möhle R; Weller M; Wick W
    Brain; 2006 Sep; 129(Pt 9):2426-35. PubMed ID: 16835250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
    Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
    J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
    Fehlauer F; Muench M; Richter E; Rades D
    Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells.
    van Nifterik KA; Van Den Berg J; Slotman BJ; Van Rijn J
    Int J Radiat Biol; 2011 Feb; 87(2):192-201. PubMed ID: 21067299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
    Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
    J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
    Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
    J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis.
    Ueno H; Tomiyama A; Yamaguchi H; Uekita T; Shirakihara T; Nakashima K; Otani N; Wada K; Sakai R; Arai H; Mori K
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):240-7. PubMed ID: 26518652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M; Rabkin S; Martuza RL
    J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase.
    Wick W; Wick A; Schulz JB; Dichgans J; Rodemann HP; Weller M
    Cancer Res; 2002 Mar; 62(6):1915-9. PubMed ID: 11912174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
    Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E
    Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
    Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
    Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
    Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
    Wang Y; Gao S; Wang W; Liang J
    Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.